Regencell Bioscience (RGC) Institutional Ownership $13.82 +0.97 (+7.55%) As of 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Regencell Bioscience (NASDAQ:RGC)CurrentInstitutional OwnershipPercentage0.13%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$11.13MNumber ofInstitutional Sellers(last 12 months)0 Get RGC Insider Trade Alerts Want to know when executives and insiders are buying or selling Regencell Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data RGC Institutional Buying and Selling by Quarter Regencell Bioscience Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/27/2025 Squarepoint Ops LLC99,843$1.70M0.0%N/A0.000% 8/15/2025 BNP Paribas Financial Markets45,050$768K0.0%N/A0.000% 8/14/2025 Squarepoint Ops LLC99,843$1.70M0.0%N/A0.000% 8/8/2025 Geode Capital Management LLC391,066$6.66M0.0%+5,637.5%0.000% 8/1/2025 Y Intercept Hong Kong Ltd13,042$222K0.0%N/A0.003% 7/7/2025 Greenfield Savings Bank11,000$187K0.1%N/A0.000% (Data available from 1/1/2016 forward) RGC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RGC shares? During the previous two years, the following institutional investors and hedge funds held shares of Regencell Bioscience shares: Geode Capital Management LLC ($6.66M), Squarepoint Ops LLC ($1.70M), BNP Paribas Financial Markets ($768K), and Y Intercept Hong Kong Ltd ($222K), Greenfield Savings Bank ($187K).Learn more on Regencell Bioscience's institutional investors. What percentage of Regencell Bioscience's stock is owned by institutional investors? 0.13% of Regencell Bioscience's stock is owned by institutional investors. Learn more on RGC's institutional investor holdings. Which institutional investors have been buying Regencell Bioscience's stock? The following institutional investors have purchased Regencell Bioscience's stock in the last 24 months: Geode Capital Management LLC ($384.25K), Squarepoint Ops LLC ($199.69K), BNP Paribas Financial Markets ($45.05K), Y Intercept Hong Kong Ltd ($13.04K), and Greenfield Savings Bank ($11K). How much institutional buying is happening at Regencell Bioscience? Institutional investors have bought a total of 653,028 shares in the last 24 months. This purchase volume represents approximately $11.13M in transactions. Related Companies GLPG Institutional Ownership NTHI Institutional Ownership PULM Institutional Ownership This page (NASDAQ:RGC) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regencell Bioscience Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Regencell Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
